News Announcement

Vivanza Biosciences: Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December 2019 regarding submission of Statement of Deviation or Variation from proceeds of public issue/rights issue/preferential issue Qualified Institutions Placement (QIP) etc. We hereby confirm that the Company has not raised any further fund by the means of Public Issue Rights Issue or Preferential Issue etc. Hence the Statement of deviation(s) or variation(s) is not being provided as it is not applicable to the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.